Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar in advanced renal cell carcinoma
NCT00492986Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2005
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of sorafenib in renal cell carcinoma (RCC), sponsored by Bayer. Started Oct 2005; status: completed.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00492986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492986.